4//SEC Filing
Assad Shawn 4
Accession 0001209191-23-033108
CIK 0001818331other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:17 PM ET
Size
15.6 KB
Accession
0001209191-23-033108
Insider Transaction Report
Form 4
Assad Shawn
Chief Accounting Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-07-01+5,139→ 37,246 total - Exercise/Conversion
Class A Common Stock
2022-08-10+10,457→ 46,206 total - Exercise/Conversion
Restricted Stock Unit
2022-07-01−5,139→ 77,097 total→ Class A Common Stock (5,139 underlying) - Exercise/Conversion
Restricted Stock Unit
2022-08-10−10,457→ 115,037 total→ Class A Common Stock (10,457 underlying) - Sale
Class A Common Stock
2022-07-05$1.32/sh−1,497$1,974→ 35,749 total - Sale
Class A Common Stock
2022-08-12$2.17/sh−3,166$6,870→ 43,040 total
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F5]1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873887
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:17 PM ET
- Size
- 15.6 KB